143 related articles for article (PubMed ID: 6473161)
1. Specific decrease of secretin/VIP-stimulated adenylate cyclase in the heart from the Lyon strain of hypertensive rats.
Robberecht P; Gillet L; Chatelain P; De Neef P; Camus JC; Vincent M; Sassard J; Christophe J
Peptides; 1984; 5(2):355-8. PubMed ID: 6473161
[TBL] [Abstract][Full Text] [Related]
2. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
Christophe J; Waelbroeck M; Chatelain P; Robberecht P
Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
[TBL] [Abstract][Full Text] [Related]
3. Impairment of hormone-stimulated cardiac adenylate cyclase activity in the genetically obese (fa/fa) Zucker rat.
Chatelain P; Robberecht P; De Neef P; Camus JC; Poloczek P; Christophe J
Pflugers Arch; 1981 Apr; 390(1):10-6. PubMed ID: 6264381
[TBL] [Abstract][Full Text] [Related]
4. Secretin and VIP-stimulated adenylate cyclase from rat heart. II. Impairment in spontaneous hypertension.
Chatelain P; Robberecht P; De Neef P; Camus JC; Heuse D; Christophe J
Pflugers Arch; 1980 Dec; 389(1):29-35. PubMed ID: 7193464
[TBL] [Abstract][Full Text] [Related]
5. Secretin and VIP-stimulated adenylate cyclase from rat heart. I. General properties and structural requirements for enzyme activation.
Chatelain P; Robberecht P; De Neef P; Deschodt-Lanckman M; König W; Christophe J
Pflugers Arch; 1980 Dec; 389(1):21-7. PubMed ID: 7193463
[TBL] [Abstract][Full Text] [Related]
6. Early decrease in secretin-, glucagon-, and isoproterenol-stimulated cardiac adenylate cyclase activity in rats treated with isoproterenol.
Chatelain P; Robberecht P; De Neef P; Camus JC; Christophe J
Biochem Pharmacol; 1982 Feb; 31(3):347-52. PubMed ID: 6280726
[TBL] [Abstract][Full Text] [Related]
7. Alterations of rat cardiac adenylate cyclase activity with age.
Robberecht P; Gillard M; Waelbroeck M; Camus JC; De Neef P; Christophe J
Eur J Pharmacol; 1986 Jul; 126(1-2):91-5. PubMed ID: 3758167
[TBL] [Abstract][Full Text] [Related]
8. Alteration of secretin-stimulated cardiac adenylate cyclase activity in rats with portacaval shunt.
De Fontaine S; Robberecht P; De Neef P; Christophe J
Peptides; 1986; 7(4):645-9. PubMed ID: 3763438
[TBL] [Abstract][Full Text] [Related]
9. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J
Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875
[TBL] [Abstract][Full Text] [Related]
10. Decreased secretin and glucagon responsiveness of adenylate cyclase in cardiac membranes from hypothyroid rats.
Robberecht P; Pochet R; Chatelain P; Verloes A; Camus JC; de Neef P; Christophe J
FEBS Lett; 1981 Sep; 132(1):33-6. PubMed ID: 7297686
[No Abstract] [Full Text] [Related]
11. Topographical distribution of the secretin- and VIP-stimulated adenylate cyclase system in the heart of five animal species.
Chatelain P; Robberecht P; Waelbroeck M; De Neef P; Camus JC; Huu AN; Roba J; Christophe J
Pflugers Arch; 1983 Apr; 397(2):100-5. PubMed ID: 6866728
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the VIP- and secretin-stimulated adenylate cyclase system from human lung.
Taton G; Delhaye M; Camus JC; de Neef P; Chatelain P; Robberecht P; Christophe J
Pflugers Arch; 1981 Sep; 391(3):178-82. PubMed ID: 6126856
[TBL] [Abstract][Full Text] [Related]
13. The adenylate cyclase activity in heart membranes from normotensive and spontaneously hypertensive rats, after chemical sympathectomy, suggests the presence of presynaptic secretin receptors.
Chatelain P; Robberecht P; Camus JC; De Neef P; Waelbroeck M; Roba J; Christophe J
Eur J Pharmacol; 1983 Sep; 93(3-4):271-6. PubMed ID: 6315454
[TBL] [Abstract][Full Text] [Related]
14. Effect of secretin, glucagon and vasoactive intestinal peptide on the hormone-sensitive rat cardiac adenylate cyclase [proceedings].
Chatelain P; Deschodt-Lanckman M; De Neef P; Christophe J; Robberecht P
Arch Int Physiol Biochim; 1979 Oct; 87(4):783-4. PubMed ID: 93901
[No Abstract] [Full Text] [Related]
15. Low responsiveness of cardiac adenylate cyclase activity to peptide hormones in spontaneously hypertensive rats.
Chatelain P; Robberecht P; de Neef P; Claeys M; Christophe J
FEBS Lett; 1979 Nov; 107(1):86-90. PubMed ID: 499563
[No Abstract] [Full Text] [Related]
16. Adenylate cyclase stimulation by VIP in rat and human parotid membranes.
van Bogaert P; Soukias Y; Dehaye JP; Lambert M; Poloczek P; Winand J; Mayer R; Christophe J
Regul Pept; 1987 Jun; 17(6):339-48. PubMed ID: 3602475
[TBL] [Abstract][Full Text] [Related]
17. Evidence that helodermin, a newly extracted peptide from Gila monster venom, is a member of the secretin/VIP/PHI family of peptides with an original pattern of biological properties.
Robberecht P; Waelbroeck M; Dehaye JP; Winand J; Vandermeers A; Vandermeers-Piret MC; Christophe J
FEBS Lett; 1984 Jan; 166(2):277-82. PubMed ID: 6319194
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of retinal adenylate cyclase by vasoactive intestinal peptide (VIP).
Longshore MA; Makman MH
Eur J Pharmacol; 1981 Mar; 70(2):237-40. PubMed ID: 7262187
[TBL] [Abstract][Full Text] [Related]
19. Selective alteration of secretin-stimulated cardiac adenylate cyclase activity in streptozotocin-diabetic rats.
Chatelain P; Gillet L; Waelbroeck M; Camus JC; Robberecht P; Christophe J
Horm Metab Res; 1983 Dec; 15(12):620-2. PubMed ID: 6229463
[TBL] [Abstract][Full Text] [Related]
20. Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes.
Robberecht P; Chatelain P; De Neef P; Camus JC; Waelbroeck M; Christophe J
Biochim Biophys Acta; 1981 Nov; 678(1):76-82. PubMed ID: 6118184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
